Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (341-350 of 349) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 349 results.
The New England Journal of Medicine|March 30, 2026
Left Atrial Appendage Closure or Anticoagulation for Atrial FibrillationShephal K Doshi, Saibal Kar, Devi G Nair, et al.
The New England Journal of Medicine|September 29, 2019
Five-Year Outcomes after PCI or CABG for Left Main Coronary DiseaseGregg W Stone, A Pieter Kappetein, Joseph F Sabik, et al.
The New England Journal of Medicine|April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial InfarctionC Michael Gibson, Danielle Duffy, Serge Korjian, et al.
The New England Journal of Medicine|September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure|June 22, 2013
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus documentFaiez Zannad, Angeles Alonso Garcia, Stefan D Anker, et al.
The New England Journal of Medicine|August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure|March 28, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessmentMartin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, et al.
The New England Journal of Medicine|August 26, 2022
Polypill Strategy in Secondary Cardiovascular PreventionJose M Castellano, Stuart J Pocock, Deepak L Bhatt, et al.
Pageof 35

Showing results (341-350 of 349) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 349 results.
The New England Journal of Medicine|March 30, 2026
Left Atrial Appendage Closure or Anticoagulation for Atrial FibrillationShephal K Doshi, Saibal Kar, Devi G Nair, et al.
The New England Journal of Medicine|September 29, 2019
Five-Year Outcomes after PCI or CABG for Left Main Coronary DiseaseGregg W Stone, A Pieter Kappetein, Joseph F Sabik, et al.
The New England Journal of Medicine|April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial InfarctionC Michael Gibson, Danielle Duffy, Serge Korjian, et al.
The New England Journal of Medicine|September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure|June 22, 2013
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus documentFaiez Zannad, Angeles Alonso Garcia, Stefan D Anker, et al.
The New England Journal of Medicine|August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure|March 28, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessmentMartin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, et al.
The New England Journal of Medicine|August 26, 2022
Polypill Strategy in Secondary Cardiovascular PreventionJose M Castellano, Stuart J Pocock, Deepak L Bhatt, et al.
Pageof 35